SRU Biosystems, a Woburn, MA based biotechnology firm, is developing high-throughput sensing and molecular biology technologies for rapidly screening the interactions of cells, proteins, genomic, peptide, antibody or small molecule compound libraries against a wide range of cell-based and biochemical targets. The BIND® technology represents a fundamental advance in the ability to monitor label-free biological interactions with high sensitivity and high throughput. SRU Biosystems is incorporating its technology into microtiter plates, microarray slides, and microfluidic formats to create tools that can be used to answer important biological questions for genomics, proteomics, clinical diagnostic tests, and pharmaceutical target screening.